SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.65 |
| Enterprise Value ($M) | -0.71 |
| Book Value ($M) | 6.36 |
| Book Value / Share | 1.97 |
| Price / Book | 0.57 |
| NCAV ($M) | 4.21 |
| NCAV / Share | 1.30 |
| Price / NCAV | 0.87 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.41 |
| Return on Assets (ROA) | -0.59 |
| Return on Equity (ROE) | -0.63 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.15 |
| Current Ratio | 7.15 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.99 |
| Assets | 7.14 |
| Liabilities | 0.78 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,606 | 13,830 | 33.30 | |
| 814 | 17,536 | 4.64 | |
| 8,122 | 15,552 | 52.22 | |
| 14,220 | 37,163 | 38.26 | |
| 87,523 | 215,612 | 40.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APRE – Aprea Therapeutics, Inc. | APTO – Aptose Biosciences Inc. |
| APVO – Aptevo Therapeutics Inc. | ASNS – Actelis Networks, Inc. |
| ASRT – Assertio Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io